CEO Robert A. Frist, Jr. is pleased with the company's operational performance and strong balance sheet, which enables shareholder value return via quarterly cash dividends. He also affirmed the company's dedication to capital management for optimizing long-term value and significant shareholder results.
Insider stock sales at lower prices are seen negatively, implying a reasonable lower price. High insider ownership in HealthStream may suggest management's shareholder interest. However, no insider buying in the past year raises concerns.
Based on HealthStream's ROCE and shareholder returns, it's not a strong growth stock with potential for major future gains. It may be beyond its growth phase, limiting substantial increases in stock value.
Gainers: •$Rocket Pharmaceuticals (RCKT.US)$+10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy) •$Canada Goose (GOOS.US)$+9.4% (the company reported an unexpected profit as well as better-than-expected revenue) •$SIGA Technologies (SIGA.US)$+6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...
RDK79
:
Deutsche Bank initiates today at Buy - PT $124. Would have been nice if they’d done this when it was in the low 80s recently. Looks like Deutche is behind the curve, and wondering if their funds bought in the 80s, then initiated the Buy….
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
HealthStream Stock Forum
• $Rocket Pharmaceuticals (RCKT.US)$ +10.5% (Presents Positive Top-line Data from Severe Leukocyte Adhesion Deficiency-I Program at the 25th Annual Meeting of the American Society of Gene and Cell Therapy)
• $Canada Goose (GOOS.US)$ +9.4% (the company reported an unexpected profit as well as better-than-expected revenue)
• $SIGA Technologies (SIGA.US)$ +6.4% (FDA approves Intravenous (IV) Formulation of TPOXX (tecovirimat) for t...
In reaction to earnings/quidance:
• $Gitlab (GTLB.US)$ +8.8%, $Dole plc (DOLE.US)$ +2.6%, $TransUnion (TRU.US)$ +1.1%
Other news:
- $Hollysys Automation Technologies (HOLI.US)$ +12% (report of takeover interest from a company in China)
- $Anavex Life Sciences (AVXL.US)$ +10.2% (Phase 2 Clinical Biomarker Data from ANAVEX 2-73-PDD-001)
- $Delta Air Lines (DAL.US)$ +4.6% (provides 01 update)
- $Air Transport Services (Delisted) (ATSG.US)$ +4.3% (plac...
- $Hollysys Automation Technologies (HOLI.US)$ +12% (report of takeover interest from a company in China)
- $Anavex Life Sciences (AVXL.US)$ +10.2% (Phase 2 Clinical Biomarker Data from ANVEX 2-73-PDD-001)
- $Delta Air Lines (DAL.US)$ +4.6%(povides Q1 update)
- $Air Transport Services (Delisted) (ATSG.US)$ +4.3% (places second order with Boeing for the conversion of four 767-300 aircraft)
- $United Airlines (UAL.US)$ +3.7% (provides Q1 upd...
No comment yet